Virbac SA
PAR:VIRP

Watchlist Manager
Virbac SA Logo
Virbac SA
PAR:VIRP
Watchlist
Price: 334.5 EUR -0.74%
Market Cap: 2.8B EUR
Have any thoughts about
Virbac SA?
Write Note

Virbac SA
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Virbac SA
Total Equity Peer Comparison

Comparables:
SAN
IPN
VETO
BOI
MEDCL

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Virbac SA
PAR:VIRP
Total Equity
€994.3m
CAGR 3-Years
12%
CAGR 5-Years
15%
CAGR 10-Years
10%
Sanofi SA
PAR:SAN
Total Equity
€72.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ipsen SA
PAR:IPN
Total Equity
€4B
CAGR 3-Years
19%
CAGR 5-Years
15%
CAGR 10-Years
15%
Vetoquinol SA
PAR:VETO
Total Equity
€543m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
8%
Boiron SA
PAR:BOI
Total Equity
€372.9m
CAGR 3-Years
-9%
CAGR 5-Years
-4%
CAGR 10-Years
0%
Medincell SA
PAR:MEDCL
Total Equity
-€40.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Virbac SA's Total Equity?
Total Equity
994.3m EUR

Based on the financial report for Jun 30, 2024, Virbac SA's Total Equity amounts to 994.3m EUR.

What is Virbac SA's Total Equity growth rate?
Total Equity CAGR 10Y
10%

Over the last year, the Total Equity growth was 11%. The average annual Total Equity growth rates for Virbac SA have been 12% over the past three years , 15% over the past five years , and 10% over the past ten years .

Back to Top